1. Preventive Oncology

Preventive oncology is any measure that is taken to prevent development or progression of malignant process. Around one third of cancer deaths are due to the five leading behavioral and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, alcohol use, and one half of all cancer cases either arise from modifiable risk factors or can be detected as precursor lesions before the development of disease with metastatic potential.

 Prevention of cancer can take place on several different levels: primary prevention addresses the cause of cancer so disease does not occur, secondary prevention identifies disease before the onset of symptoms and keeps it from becoming more extensive, and tertiary prevention reduces complications and progression of disease once it has become clinically apparent. 

Related Cancer Conferences | Oncology Conferences

lobal Summit On Oncology & Cancer March 12-14, 2018,Singapore City, Singapore, Global Meeting On Oncology And Radiology April 16-17, 2018, Dubai, UAE, 3rd International Conference On Neuro-Oncology And Brain Tumor April 19-20, 2018, Dubai, UAE, 27 Th International Conference On Oncology Research & Cancer Stem Cells May 10-12, 2018, Frankfurt, Germany, 29th Euro-Global Summit On Cancer Therapy & Radiation Oncology July 23-25, 2018, Rome, Italy International Congress On Targeted Anticancer Therapies March 05 –07, 2018, Paris, France, European Lung Cancer Congress April 11-14, 2018, Geneva, Switzerland, The ESMO Sarcoma & GIST Symposium  February  5-7, 2018,Milan, Italy, American Association for Cancer Research Annual Meeting April 14-18, 2018, Chicago,USA

2. Cancer Cell Biology

The cell is the key unit of life. It is the littlest structure of the body equipped for playing out the majority of the procedures that characterize life. Each of the organs in the body, for example, the lung, bosom, colon, and cerebrum, comprises of specific cells that complete the organ's capacities, for example, the transportation of oxygen, assimilation of supplements, discharge of waste materials, velocity, generation, considering. when this process breaks down, cancer begins to form. Cancer cells will be cells that gap persistently, shaping strong tumors or flooding the blood with unusual cells. Cell division is a typical procedure utilized by the body for development and repair.

Related Cancer Conferences |  Cancer Meetings | Cancer Events

33rd International Conference On Oncology Nursing And Cancer Care September 17-18, 2018,Bali, Indonesia, International Conference On Robotic Oncology October 26-27, 2018,Osaka, Japan, Colorectal Cancer 2018,  Baltimore, USA, 22nd Global Annual Oncologists Meeting, May 24-25, 2018, Osaka, Japan, World Haematology and Medical Oncology Conference May 28-30, 2018,  Osaka, Japan, 3rd Oncologist & Diagnostics Conference, September 20-21, 2018, Berlin, Germany, Experts Meet on Cancer Therapy , July 11-12, 2018, Sydney, Australia,Molecular Pathology Approach to Cancer, June 4–6,  2018, Amsterdam, Germany, A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments, February 1-3, 2018, Netherlands, 4th Conference on Cancer Genomics June  23 -26, 2019, Cambridge, UK

3. Anti Cancer Drugs and Pharmacotherapeutics

4. Radiation Oncology

The branch of Oncology dealing with Radiation therapy is termed as Radiation Oncology. The Radiotherapy is broadly segmented into Teleradiotherapy, Brachy-radiotherapy and Metabolic Radiotherapy. Tele-radiotherapy, also called as External transcutaneous / distant radiotherapy, is a method in which the radiation source is situated at a certain distance from the tissue to be treated. Brachytherapy, also termed as Short direct radiotherapy /Curitherapy, is a method in which radiation source can be placed in contact with the tumor or it can be implanted in the tumor. Curative radiotherapy is indicated to be used in: Sticker’s sarcoma, Mastocytomas with particular locations, such as ears, nose, extremities, eyelids; Nasal cavity adenocarcinoma and Anal gland adenocarcinoma. Stereotactic radiosurgery is a single-day procedure for treating small intracranial lesions. Metabolic radiotherapy represents the administration of isotopes or isotope carrying molecules that selectively concentrate in a certain tissue into which they enter as metabolites. For Example; iodine-131is used in treating Thyroid cancer; phosphorus-32 is used in treating Myeloproliferative disorders.

• Radiation Therapy
• Predictive Oncology
• Cancer Imaging
• Stem Cell Therapy
• Oncology Nursing
• Radiation therapy
• Stereotactic body radiation therapy (SBRT)
• Intensity Modulated Radiotherapy (IMRT)
• Intravascular brachytherapy
• Prostate Seed Implant

Related Conferences

Global Meeting On Oncology And Radiology April 16-17, 2018, Dubai, UAE, 3rd International Conference On Neuro-Oncology And Brain Tumor April 19-20, 2018, Dubai, UAE, 27 Th International Conference On Oncology Research & Cancer Stem Cells May 10-12, 2018, Frankfurt, Germany, European Lung Cancer Congress April 11-14, 2018, Geneva, Switzerland, The ESMO Sarcoma & GIST Symposium  February  5-7, 2018,Milan, Italy, American Association for Cancer Research Annual Meeting April 14-18, 2018, Chicago,USA

5. Stem-Cell Therapy

The branch of medication that arrangements with the conclusion and treatment of harm, disfigurement, and infection by the utilization of instruments. Immature microorganism treatment is the utilization of undifferentiated cells to treat or keep an illness or condition. Undifferentiated organisms have colossal guarantee to help us comprehend and treat a scope of illnesses, wounds and other wellbeing related conditions. Their potential is apparent in the utilization of blood undifferentiated organisms to treat ailments of the blood, a treatment that has spared the lives of a great many youngsters with leukemia; and can be found in the utilization of undeveloped cells for tissue unions to treat infections or harm deep down, skin and surface of the eye. Some bone, skin and corneal (eye) wounds and infections can be dealt with by uniting or embedding tissues, and the mending procedure depends on undifferentiated organisms inside this embedded tissue. A bone marrow transplant is a system to supplant harmed or wrecked bone marrow with solid bone marrow undeveloped cells.

• Hormonal Therapy
• Targeted Therapy
• LASER and LASIC
• Immunotherapy
• Stem cell transplantation
• Proton therapy
• Bone marrow Transplantation
• Stem cells: therapeutic uses
• Oral stem cell therapy
• Allogeneic bone marrow transplantation
• Stem cell replacement
• Malignant and non-malignant diseases
• Neurodegeneration
• Gene Therapy
• Angiogenesis Inhibitors

Related Societies

UK Oncology Nursing Children’s Cancer and Leukaemia Group Society; Childhood Cancer Research Group Cancer Focus BASO; European Society for Medical Oncology; European Oncology Nursing Society; European Society of Oncologic Imaging; European Association for Cancer Research; American Cancer Society (ACS); Hematology/Oncology Pharmacy Association; American Association for Cancer Research (AACR); Association of International Cancer Research; International Agency for Research on Cancer (IARC); Asian Clinical Oncology Society (ACOS); Asian Oncology Nursing Society(AONS); Asian Society of Gynecologic Oncology (ASGO); Asian Society for Neuro-Oncology (ASNO); Asian Society of Head & Neck Oncology (ASHNO);

6. Cancer Diagnosis

Cancer Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. At Cancer Treatment Centres. We use sophisticated diagnostic technology to pinpoint and evaluate tumors, and develop a personalized treatment plan. Some cancers are diagnosed during routine screening examinations. These are usually tests that are routinely done at a certain age. Many cancers are discovered when you present to your health care professional with specific symptoms.

• A review of health history
• Physical examination
• Laboratory tests (blood, urine, etc.)
• Biopsy
• Imaging tests (X-ray, PET/CT, MRI, ultrasound, etc.)
• Nuclear medicine scans (bone scans, etc.)
• Endoscopy
• Genetic tests

Related Cancer Conferences |  Cancer Meetings | Cancer Events

27 Th International Conference On Oncology Research & Cancer Stem Cells May 10-12, 2018, Frankfurt, Germany, 29th Euro-Global Summit On Cancer Therapy & Radiation Oncology July 23-25, 2018, Rome, Italy International Congress On Targeted Anticancer Therapies March 05 –07, 2018, Paris, France, European Lung Cancer Congress April 11-14, 2018,Global Meeting On Oncology And Radiology April 16-17, 2018, Dubai, UAE, 3rd International Conference On Neuro-Oncology And Brain Tumor April 19-20, 2018, Dubai, UAE, 27 Th International Conference On Oncology Research & Cancer Stem Cells May 10-12, 2018, Frankfurt, Germany,

7. Molecular and Cellular Oncology

Molecular and Cellular Oncology's main goal is to improve essential exploration incredibleness by setting up a solid examination bunch concentrated on the sub-atomic and cell parts of growth exploration, especially in sub-atomic and cell flagging pathways for tumor movement and metastasis; to upgrade translational exploration for advancement of focused malignancy treatments; to improve instructive projects for cutting edge researchers.

• Cell and Molecular Pharmacology & Experimental Therapeutics
• Genetic
• Epigenetic
• Biochemical
• Oncogene signalling
• Metabolism
• Angiogenesis

Related Cancer Conferences |  Cancer Meetings | Cancer Events

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

8. Immuno Oncology

The most recent energizing examination leap forward for disease treatment is in the field of immuno-oncology. This type of treatment uses or upgrades the patient's own particular insusceptible framework to have the capacity to stop the development of malignancy cells.

The insusceptible framework is the body's common barrier framework. It is an accumulation of organs, cells and exceptional atoms that shields you from contaminations, tumor and different maladies. At the point when an alternate (remote) life form goes into the body, for instance a microscopic organisms, the resistant framework remembers it and after that assaults it, keeping it from creating hurt. This procedure is called an insusceptible reaction. Since malignancy cells are altogether different from typical cells in the body, the resistant framework assaults them when it can remember them. Notwithstanding, disease cells regularly discover approaches to mask themselves as typical cells, so that the safe framework does not generally remember them as unsafe. What's more, like infections, they can change after some time (transform) and hence escape from the insusceptible reaction. Additionally, the characteristic safe reaction to disease cells is frequently not sufficiently solid to battle off growth cells. Immuno-oncology treatments enact our insusceptible framework, making it ready to perceive growth cells and decimate them.

• Tumor immunology
• Immune suppression
• Antitumour
• Tumour-associated antigens
• Tumour microenvironment
• Enhancing Adaptive Anti-Tumor Responses
• Prediction and Prognosis in Immunotherapy
• Preclinical and clinical development
• Cell and gene therapy
• Immunology
• Biomarker discovery
• Antibody and protein engineering
• Immuno-resistive drugs
• Immuno surveillance

Related Societies

UK Oncology Nursing Children’s Cancer and Leukaemia Group Society; Childhood Cancer Research Group Cancer Focus BASO; European Society for Medical Oncology; European Oncology Nursing Society; European Society of Oncologic Imaging; European Association for Cancer Research; American Cancer Society (ACS); Hematology/Oncology Pharmacy Association; American Association for Cancer Research (AACR); Association of International Cancer Research; International Agency for Research on Cancer (IARC); Asian Clinical Oncology Society (ACOS); Asian Oncology Nursing Society(AONS); Asian Society of Gynecologic Oncology (ASGO); Asian Society for Neuro-Oncology (ASNO); Asian Society of Head & Neck Oncology (ASHNO);

9. Cancer Prognosis

A prognosis is the doctor's best estimate of how cancer will affect a person. Many factors can affect a person's prognosis. Survival statistics are one tool that doctors use to develop a prognosis for a person with cancer. Doctors often look at studies that measure survival for a particular type of cancer, stage or risk group, when developing a prognosis.

There are different types of cancer survival statistics and different ways to measure and report survival. In general, survival is the proportion of people with cancer who are alive at some point in time (such as 1, 3, 5 or 10 years) after their diagnosis. Type of cancer

• Stage
• Characteristics of the cancer
• Treatments chosen
• Response to treatment

Related Cancer Conferences | Oncology Conferences

lobal Summit On Oncology & Cancer March 12-14, 2018,Singapore City, Singapore, Global Meeting On Oncology And Radiology April 16-17, 2018, Dubai, UAE, 3rd International Conference On Neuro-Oncology And Brain Tumor April 19-20, 2018, Dubai, UAE, 27 Th International Conference On Oncology Research & Cancer Stem Cells May 10-12, 2018, Frankfurt, Germany, 29th Euro-Global Summit On Cancer Therapy & Radiation Oncology July 23-25, 2018, Rome, Italy International Congress On Targeted Anticancer Therapies March 05 –07, 2018, Paris, France, European Lung Cancer Congress April 11-14, 2018, Geneva, Switzerland, The ESMO Sarcoma & GIST Symposium  February  5-7, 2018,Milan, Italy, American Association for Cancer Research Annual Meeting April 14-18, 2018, Chicago,USA

10. Cancer Vaccines

A cancer vaccine is an antibody that either treats existing disease or forestalls advancement of a malignancy. Antibodies that regard existing growth are known as restorative malignancy immunizations. Malignancy immunizations help the resistant framework's normal capacity to perceive and annihilate things that are remote and possibly unsafe to the body. A solid, sound resistant framework can distinguish antigens and assault them, ordinarily dispensing with them. A malignancy treatment antibody exploits the resistant framework's reaction to antigens. Regularly, tumor cells have particular particles on their surface that are not present on solid cells. At the point when infused into a man, these particular atoms go about as antigens, which empower the safe framework to perceive and pulverize tumor cells that have these particles on their surface. Most disease antibodies additionally contain adjuvants. Malignancy immunizations are two sorts they are Preventive (or prophylactic) antibodies.

• Immunotherapy on targeting cancer gene therapy
• Prophylactic Vaccine
• Cancer Therapeutic Vaccines
• Preventive cancer vaccines
• Immunotherapy of cancer vaccines
• Research on cancer vaccines
• Cancer Immuno vaccine

Related Cancer Conferences |  Cancer Meetings | Cancer Events

33rd International Conference On Oncology Nursing And Cancer Care September 17-18, 2018,Bali, Indonesia, International Conference On Robotic Oncology October 26-27, 2018,Osaka, Japan, Colorectal Cancer 2018,  Baltimore, USA, 22nd Global Annual Oncologists Meeting, May 24-25, 2018, Osaka, Japan, World Haematology and Medical Oncology Conference May 28-30, 2018,  Osaka, Japan, 3rd Oncologist & Diagnostics Conference, September 20-21, 2018, Berlin, Germany, Experts Meet on Cancer Therapy , July 11-12, 2018, Sydney, Australia,Molecular Pathology Approach to Cancer, June 4–6,  2018, Amsterdam, Germany, A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments, February 1-3, 2018, Netherlands, 4th Conference on Cancer Genomics June  23 -26, 2019, Cambridge, UK

11. Gynecologic Oncology

Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. Cancer of the female reproductive tract also includes the endometrium,  tallopian tubes, and vagina. The specialists in this do have extensive training in the diagnosis and treatment of these cancers. By the Aggressive exploitation of operative laparoscopy, even only for selected patients, into the surgical practice of a gynecologic oncology service demonstrates significant improvements in LOS (laparoscopy on length of stay) without adversely affecting surgical complication rates based on different types of cancers. Cervical cancer Endometrial/uterine cancer Gestational trophoblastic disease Ovarian cancer- including fallopian tube, peritoneal, germ cell, and stromal cell Vaginal cancer Vulvar cancer.

• Cervical cancer
• Endometrial /Uterine Cancer
• Gestational trophoblastic disease
• Vaginal cancer
• The adnexal mass
• Epithelial ovarian cancer
• Breast cancer
• Sarcoma of the uterus

Related Cancer Conferences |  Cancer Meetings | Cancer Events

33rd International Conference On Oncology Nursing And Cancer Care September 17-18, 2018,Bali, Indonesia, International Conference On Robotic Oncology October 26-27, 2018,Osaka, Japan, Colorectal Cancer 2018,  Baltimore, USA, 22nd Global Annual Oncologists Meeting, May 24-25, 2018, Osaka, Japan, World Haematology and Medical Oncology Conference May 28-30, 2018,  Osaka, Japan,  27 Th International Conference On Oncology Research & Cancer Stem Cells May 10-12, 2018, Frankfurt, Germany, European Lung Cancer Congress April 11-14, 2018, Geneva, Switzerland, The ESMO Sarcoma & GIST Symposium  February  5-7, 2018,Milan, Italy, American Association for Cancer Research Annual Meeting April 14-18, 2018, Chicago,USA

12. Pediatric Oncology

Pediatic Oncology is a branch of medicine which deals with the medical care of infants, children, and adolescents. The word pediatrics and its cognates mean "healer of children"; they derive from two Greek words: pais "child" and iatros "doctor, healer". The age limit, from birth up to 18-21 yrs. Pediatricians work both in primary care physicians and hospitals, especially they works in a specialized subfields such as neonatology. Paediatric oncologists diagnose, treat, and manage children, suffering from cancers which include leukaemia, lymphomas, brain tumours, bone tumours, and solid tumors. A medical practitioner who specializes in this area is called as a paediatrician. The body of an infant or neonate is substantially physiologically different when compare to an adult. Congenital defects, genetic variance and developmental issues are some greater concern to paediatricians as compare to adult physicians.

• Types of Pediatric Oncology
• Pleuropulmonary Blastoma
• Germ Cell Tumor
•  Retinoblastoma
• Non-Hodgkin lymphoma
• Wilms tumor
• Neuroblastoma
• Pediatric Hematology Oncology
• Clinical Pediatrics
• Pediatric Cancer Care
• Pediatric Oncology Nursing
• Pediatric Oncology Treatment
• Pediatric Oncology Diagnosis
• Pediatric Neuro- Oncology
• Pediatric Radiology
• Pediatric Leukemia
• Hepatoblastoma

Related Cancer Conferences |  Cancer Meetings | Cancer Events

11th European Breast Cancer Conferences, March 21-23, 2018, Barcelona, Spain; AACR-NCI-EORTC International Cancer Molecular Targets Conferences and Cancer Therapeutics Conferences, August 26-27, 2018, United States of America; 5th Annual International Advances in Hematology Conferences and Oncology Conferences, August 12-13, 2017, USA; Cancer Conferences USA 2018 International Conferences on Clinical Trials in Oncology and Hemato-Oncology Conferences 2018, February19-20, 2018, Berlin, Germany; 33rd German Cancer Conferences 2018, February 21-24,2018, Berlin, Germany; Cancer Conferences Japan 2018 2nd International Epigenetics Conferences & Chromatin Conferences, November 06-08, 2017 Frankfurt, Germany.

13. Bone Marrow Transplantation

Bone marrow transplantation is the strategy to supplant harmed bone marrow cells with solid bone marrow cells of the same individual or in another good individual to reestablish the ordinary generation of platelets. It is otherwise called Hematopoietic undifferentiated organism transplantation (HSCT). It is the transplantation of multipotent hematopoietic undifferentiated cells, typically got from bone marrow, fringe blood, or umbilical line blood. It might be autologous (the patient's own particular foundational microorganisms are utilized), allogeneic (the immature microorganisms originate from a giver) or syngeneic ( from an indistinguishable twin ). It is a restorative strategy in the field of hematology, frequently performed for patients with specific malignancies of the blood or bone marrow, for example, numerous myeloma or leukemia. In these cases, the beneficiary's safe framework is typically demolished with radiation or chemotherapy before the transplantation. Contamination and joining versus-host malady are real entanglements of allogeneic HSCT.

• Autologous Bone marrow Transplantation
• Allogeneic Bone marrow Transplantation
• Syngeneic Bone marrow Transplantation

Related Cancer Conferences |  Cancer Meetings | Cancer Events

11th European Breast Cancer Conferences, March 21-23, 2018, Barcelona, Spain; AACR-NCI-EORTC International Cancer Molecular Targets Conferences and Cancer Therapeutics Conferences, August 26-27, 2018, United States of America; 5th Annual International Advances in Hematology Conferences and Oncology Conferences, August 12-13, 2017, USA; Cancer Conferences USA 2018 International Conferences on Clinical Trials in Oncology and Hemato-Oncology Conferences 2018, February19-20, 2018, Berlin, Germany; 33rd German Cancer Conferences 2018, February 21-24,2018, Berlin, Germany; Cancer Conferences Japan 2018 2nd International Epigenetics Conferences & Chromatin Conferences, November 06-08, 2017 Frankfurt, Germany.

14. Cancer Biomarker

A biomarker, or biological marker, generally refers to a measurable indicator of some biological state or condition. The term is also occasionally used to refer to a substance the presence of which indicates the existence of a living organism. Further, life forms are known to shed unique chemicals, including DNA, into the environment as evidence of their presence in a particular location. Biomarker is a characteristic diagnostic tool that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention. Biomarkers can be molecules, or genes, gene products, enzymes, or hormones referred as protein biomarkers, analytical biomarkers, blood biomarkers, fluorescent biomarkers, circulating biomarkers and molecular biomarkers to quantify the degree of disease condition.Role of biomarkers in cancer research and medicine

• Protein biomarkers
• Fluorescent biomarkers
• Blood biomarkers: Serum and blood cells
• Analytical biomarkers
• Genetic Biomarkers
• Molecular Biomarkers

Related Conferences

Global Meeting On Oncology And Radiology April 16-17, 2018, Dubai, UAE, 3rd International Conference On Neuro-Oncology And Brain Tumor April 19-20, 2018, Dubai, UAE, 27 Th International Conference On Oncology Research & Cancer Stem Cells May 10-12, 2018, Frankfurt, Germany, European Lung Cancer Congress April 11-14, 2018, Geneva, Switzerland, The ESMO Sarcoma & GIST Symposium  February  5-7, 2018,Milan, Italy, American Association for Cancer Research Annual Meeting April 14-18, 2018, Chicago,USA

15. Organ specific cancer

Malignancy has a differentiated nature in connection to the organ specificity. The essential center is on heterogeneity, starting point, metastasis, angiogenesis and organ indicated systems in disease cells. There are diverse sorts of diseases taking into account area of tumor in the body organ. Organ-particular metastasis includes disease cell collaborations with the host microenvironment, including actuation of paracrine cytokine circles, change of the host cell sythesis, and modification of extracellular framework structures. Resistant cell avoidance, relationship with a strong specialty, and the capacity to open up survival pathways, frequently accomplished through association with the stroma, are vital for fruitful metastatic colonization.

• Multistage Carcinogenesis
• Heart cancer
• Breast cancer
• Gynaecological Cancer
• Endometrial cancer
• Hemato-Oncology
• Neuroblastoma
• Oncology Cachexia
• Ocular Melanoma
• Osteosarcoma
• Skin Cancer
• Pediatric cancer
• Neuro-Oncology
• Urology Oncology
• Otolaryngology cancers
• Oral cancer
• Thyroid Cancer
• Gastrointestinal Cancer
• Lung cancer
• Renal cancer
• Oncology : Psychological & Social Aspects

Related Societies

UK Oncology Nursing Children’s Cancer and Leukaemia Group Society; Childhood Cancer Research Group Cancer Focus BASO; European Society for Medical Oncology; European Oncology Nursing Society; European Society of Oncologic Imaging; European Association for Cancer Research; American Cancer Society (ACS); Hematology/Oncology Pharmacy Association; American Association for Cancer Research (AACR); Association of International Cancer Research; International Agency for Research on Cancer (IARC); Asian Clinical Oncology Society (ACOS); Asian Oncology Nursing Society(AONS); Asian Society of Gynecologic Oncology (ASGO); Asian Society for Neuro-Oncology (ASNO); Asian Society of Head & Neck Oncology (ASHNO);

16. Medical Imaging

Medical imaging is the method and procedure of making visual representations of the inside of a body for clinical examination and therapeutic intercession, and additionally visual representation of the capacity of a few organs or tissues. Therapeutic imaging tries to uncover interior structures covered up by the skin and bones, and additionally to analyse and treat malady. Medicinal imaging likewise builds up a database of ordinary life structures and physiology to make it conceivable to distinguish variations from the norm. In spite of the fact that imaging of expelled organs and tissues can be performed for medicinal reasons, such methodology is typically considered a portion of pathology rather than restorative imaging.

• Radiography
• Echocardiography
• Tomography
• Thermography
• Photoacoustic imaging
• Tactile imaging
• Elastography
• Ultrasound
• Nuclear medicine
• Magnetic Resonance Imaging (MRI)
• Functional near-infrared spectroscopy

Related Cancer Conferences |  Cancer Meetings | Cancer Events

33rd International Conference On Oncology Nursing And Cancer Care September 17-18, 2018,Bali, Indonesia, International Conference On Robotic Oncology October 26-27, 2018,Osaka, Japan, Colorectal Cancer 2018,  Baltimore, USA, 22nd Global Annual Oncologists Meeting, May 24-25, 2018, Osaka, Japan, World Haematology and Medical Oncology Conference May 28-30, 2018,  Osaka, Japan,  27 Th International Conference On Oncology Research & Cancer Stem Cells May 10-12, 2018, Frankfurt, Germany, European Lung Cancer Congress April 11-14, 2018, Geneva, Switzerland, The ESMO Sarcoma & GIST Symposium  February  5-7, 2018,Milan, Italy, American Association for Cancer Research Annual Meeting April 14-18, 2018, Chicago,USA

17. Carcinoma

Carcinoma is a sort of cancer that develops from epithelial cells. In particular, a carcinoma is a malignancy that starts in a tissue that lines the internal or external surfaces of the body, and that generally arises from cells developing  in the endodermal or ectodermal germ layer during embryogenesis. Carcinomas occur when the DNA of a cell is damaged or changed and the cell starts to develop wildly and get to be distinctly threatening. There are large number of rare sub types  of anaplastic, undifferentiated carcinoma.Some of the more well-known cancers  includes the lesions containing pseudo-sarcomatous segments: spindle cell carcinoma (containing prolonged cells resembling connective tissue malignancies), giant cell carcinoma (containing gigantic, peculiar, multinucleated cells), and sarcomatoid carcinoma (blends of shaft and monster cell carcinoma).

• Invasive ductal carcinoma
• Ductal carcinoma in situ
• Renal cell carcinoma
• Basal cell carcinoma
• Carcinoma treatment and therapy option

Related Conferences

Global Meeting On Oncology And Radiology April 16-17, 2018, Dubai, UAE, 3rd International Conference On Neuro-Oncology And Brain Tumor April 19-20, 2018, Dubai, UAE, 27 Th International Conference On Oncology Research & Cancer Stem Cells May 10-12, 2018, Frankfurt, Germany, European Lung Cancer Congress April 11-14, 2018, Geneva, Switzerland, The ESMO Sarcoma & GIST Symposium  February  5-7, 2018,Milan, Italy, American Association for Cancer Research Annual Meeting April 14-18, 2018, Chicago,USA

18. Oncological Nursing

Oncology is a standout amongst the most Focused zone in Cancer Treatments.For an Oncologist or Oncology Nurse, to locate an appropriate words to cheer a man who enduring with sickness. The specific medical caretaker is an enrolled nurture whose essential concentration in tumor mind.The advanced Oncology Nurse is master’s prepared nurse with learning and capacity in a range of malignancy nursing. All medical caretakers move along a way from learners to master. It is perceived that, paying little respect to regardless of the possibility that a generalist, specific oncology or propelled Oncology Nurse, every individual medical attendant will encounter this way from amateurs to master.

• Clinical implications
• Oncology Nursing Practice
• Patient Care Measures
• Primary Care and Oncology Nursing
• Oncology Nursing and Cancer care
• Psychological and psychosocial aspects and Cancer care
• Effects of Cancer in chemotherapy and Oncology Nursing
• Oncology Nursing in USA

Related Cancer Conferences |  Cancer Meetings | Cancer Events

11th European Breast Cancer Conferences, March 21-23, 2018, Barcelona, Spain; AACR-NCI-EORTC International Cancer Molecular Targets Conferences and Cancer Therapeutics Conferences, August 26-27, 2018, United States of America; 5th Annual International Advances in Hematology Conferences and Oncology Conferences, August 12-13, 2017, USA; Cancer Conferences USA 2018 International Conferences on Clinical Trials in Oncology and Hemato-Oncology Conferences 2018, February19-20, 2018, Berlin, Germany; 33rd German Cancer Conferences 2018, February 21-24,2018, Berlin, Germany; Cancer Conferences Japan 2018 2nd International Epigenetics Conferences & Chromatin Conferences, November 06-08, 2017 Frankfurt, Germany. 

19. Cancer Genomics and Metabolomics

Oncogenomics is a relatively new sub-field of genomics that applies high throughput technologies to characterize genes associated with cancer. The study involves the research in to the Bioinformatics and functional analysis of oncogenes, which refers to the gene that has the potential to cause cancer. In tumor cells, they are often mutated or expressed at high levels. Cancer genome sequencing requires the development of new techniques utilizing Genomics and bioinformatics tools for target assessment, including both experimental protocols and data analysis algorithms, to enable a deeper understanding of complex biological systems.

Metabolomics is a newborn cousin to genomics and proteomics. Specifically, metabolomics involves the rapid, high throughput characterization of the small molecule metabolites found in an organism. The metabolome is closely tied to the genotype of an organism, its physiology and its environment (what the organism eats or breathes), metabolomics offers a unique opportunity to look at genotype-phenotype as well as.

• Pharmacology
• Potential Diagnostic Applications
• Mutations In Mitochondrial DNA And Cancer
• Advances From Oncogenomics
• Databases For Cancer Research
• Comparative Oncogenomics
• Bioinformatics And Functional Analysis Of Oncogenes
• Cancer Transcriptomes
• Cancer Genome Sequencing
• Clinical Chemistry
• Newborn Screening
• Transplant Monitoring,
• Toxicology
• Pre-Clinical Drug Trials
• Cancer Biomarkers

Related Societies

UK Oncology Nursing Children’s Cancer and Leukaemia Group Society; Childhood Cancer Research Group Cancer Focus BASO; European Society for Medical Oncology; European Oncology Nursing Society; European Society of Oncologic Imaging; European Association for Cancer Research; American Cancer Society (ACS); Hematology/Oncology Pharmacy Association; American Association for Cancer Research (AACR); Association of International Cancer Research; International Agency for Research on Cancer (IARC); Asian Clinical Oncology Society (ACOS); Asian Oncology Nursing Society(AONS); Asian Society of Gynecologic Oncology (ASGO); Asian Society for Neuro-Oncology (ASNO); Asian Society of Head & Neck Oncology (ASHNO);

20. Advancement in Preventive Oncology

As the researchers learn more about cancer, they’re developing new therapies that target particular types of tumor cells and restrict their growth. Blood carcinoma  is one of the major cancer that affect mainly blood, bone marrow, lymph and lymphatic system for treating this recent techniques have been discovered  by the researchers through targeting the tumor and restrict their growth. On their own or in combination with other alternative treatments, these therapies can decrease the size of tumors and symptoms. Some innovative therapies give hope for people with cancers that have been resistant to more treatments.

There are different stages of the cancer like Stage 1, Stage 2, Stage 3 and Stage 4. The Oncology Conference delivers practical ideas, solutions, and strategies to implement in cancer program today. This advance also speaks to the importance of value in cancer care. Value is a major focus for ASCO, because clinical benefit, toxicity, and cost must all be factored into shared decision making to determine the best treatment options for patients. ASCO is working to develop a physician-guided tool that will help patients evaluate new treatment options such as those highlighted in this report.

• Cancer and lifestyle connection
• Health education on Cancer prevention
• Global Cancer Epidemiology
• Cancer Nanotechnology

Related Cancer Conferences |  Cancer Meetings | Cancer Events

33rd International Conference On Oncology Nursing And Cancer Care September 17-18, 2018,Bali, Indonesia, International Conference On Robotic Oncology October 26-27, 2018,Osaka, Japan, Colorectal Cancer 2018,  Baltimore, USA, 22nd Global Annual Oncologists Meeting, May 24-25, 2018, Osaka, Japan, World Haematology and Medical Oncology Conference May 28-30, 2018,  Osaka, Japan,  27 Th International Conference On Oncology Research & Cancer Stem Cells May 10-12, 2018, Frankfurt, Germany, European Lung Cancer Congress April 11-14, 2018, Geneva, Switzerland, The ESMO Sarcoma & GIST Symposium  February  5-7, 2018,Milan, Italy, American Association for Cancer Research Annual Meeting April 14-18, 2018, Chicago,USA

21. Medical Chemistry

Medicinal chemistry and pharmaceutical chemistry are disciplines at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with design, chemical synthesis and development for market of pharmaceutical agents, or bio-active molecules (drugs).

Compounds used as medicines are most often organic compounds, which are often divided into the broad classes of small organic molecules (e.g., atorvastatin, fluticasone,clopidogrel) and "biologics" (infliximab, erythropoietin, insulin glargine), the latter of which are most often medicinal preparations of proteins (natural and recombinant antibodies, hormones, etc.). Inorganic and organometallic compounds are also useful as drugs (e.g., lithium and platinum-based agents such as lithium carbonate and cis-platin as well asgallium).

• Medicinal Chemical Research
• Anti-Allergic
• Chemical Biology of Molecules
• Chemical Pharmacology
• Bioorganic Medicinal Chemistry
• Medicinal Companies and Market Analysis
• Medicinal Biochemistry
•  Anticancer Agents in Medicinal Chemistry
• Applied Medicinal Chemistry
• Synthetic Medicinal Chemistry’
• Medicinal Organic Chemistry
•  Anti-Infective Agents in Medicinal Chemistry

Related Cancer Conferences |  Cancer Meetings | Cancer Events

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

22. Medical Physics

Medical physics (also called biomedical physics, medical biophysics or applied physics in medicine) is, generally speaking, the application of physics concepts, theories and methods to medicine or healthcare. Medical physics departments may be found in hospitals or universities.In the case of hospital work, the term 'Medical Physicist' is the title of a specific healthcare profession with a specific mission statement. Such Medical Physicists are often found in the following healthcare specialties: 

• Intervention Radiology
• Healthcare informatics and computational physics
• Physics of the human and animal bodies
• Physiological measurement techniques
• Cardiophysics
• Neurophysics
• Medical optics
• Laser medicine
• Clinical audiology physics
• Health physics
• Nuclear medicine physics
• Radiation therapeutic physics
• Medical imaging physics
• Radiation Protection
• Clinical Physiology
• Areas of research and academic development

Related Societies

UK Oncology Nursing Children’s Cancer and Leukaemia Group Society; Childhood Cancer Research Group Cancer Focus BASO; European Society for Medical Oncology; European Oncology Nursing Society; European Society of Oncologic Imaging; European Association for Cancer Research; American Cancer Society (ACS); Hematology/Oncology Pharmacy Association; American Association for Cancer Research (AACR); Association of International Cancer Research; International Agency for Research on Cancer (IARC); Asian Clinical Oncology Society (ACOS); Asian Oncology Nursing Society(AONS); Asian Society of Gynecologic Oncology (ASGO); Asian Society for Neuro-Oncology (ASNO); Asian Society of Head & Neck Oncology (ASHNO);

The growing need to demonstrate value in health care, including in cancer care, combined with a projected workforce shortage of clinical oncologists and nurses by 2020, suggests that cancer prevention efforts will need to be specifically targeted toward improving health outcomes while reducing healthcare costs. The passage of the Patient Protection and Affordable Care Act in March 2010, with its focus on prevention through the elimination of co-payments and deductibles for preventive services, makes the need to demonstrate value in cancer prevention even greater than before. The pace of progress in cancer care is quickening. A bunch of inventive medications frequently joined with other new or existing pharmaceuticals are rising up out of the innovative work pipeline. Many are for tumor sorts related with low survival rates and where patients have constrained alternatives. The scene is moving quickly, conveying new intricacy to oncologists, payers and governments who all hope to give proper care to patients while guaranteeing the sustainability of social insurance frameworks. Prior analysis, longer treatment length and expanded adequacy of medication treatments are adding to rising levels of spending on drugs for malignancy mind.

Oncologists know that men are more prone to cancer than women, one in two men will develop some form of the disease in a lifetime, compared with one in three women. In the past, they theorized that men were more likely than women to encounter carcinogens through factors such as cigarette smoking and factory work. Yet the ratio of men with cancer to women with cancer remained largely unchanged across time, even as women began to smoke and enter the workforce in greater numbers.  Lung and bronchial cancer causes more deaths in the United States than any other type of cancer in both men and women. Although survival rates have increased over the years, thanks to improved treatments, the outlook is still bleak.

This report examines the worldwide cancer diagnostics advertise for the gauge time of 2015 to 2020. This market is relied upon to reach $13.1 Billion by 2020 from $7.1 Billion of every 2015, and is ready to develop at a CAGR of 12.9% amid the figure time frame. Some of the major players in the global cancer diagnostics system market include Agilent Technologies, Thermo Fisher Scientific,  Illumina, Becton, Dickinson and Company ,  GE Healthcare , QIAGEN , Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Philips Healthcare and C.R. Bard among others.

The global Cancer therapy market is estimated to grow at 17.6% CAGR to reach $52.2billion by 2021.

Importance & Scope

Preventive Oncology 2018 will be the best stage for every one of the oncologists, haematologists, Pathologists, Radiologists, Academics, explore researchers, understudies who are working in this field to trade their insight identified with Cancer and treatment. This worldwide occasion is a push to comprehend the fundamental organic methodology which is revised to build adequacy, exactness, survivability, and nature of life. Experts will clarify how another era of treatment choices gives patients new trust in the battle against disease. Geographically, the worldwide disease treatment market is ordered into areas to be specific, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa .North America takes the biggest share of worldwide malignancy treatment advertise took after by Europe.

Cancer is the second leading cause of death worldwide and in all regions of the world except sub-Saharan Africa. Historically, the USA had a much lower incidence of cancer than other countries; however, over the last 40 years, it has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity.

Cancer, which is now the third leading cause of death in the USA (after cardiovascular disease and injury) causing 30% of all deaths in 2012 and 46% of all deaths in the France during the same year. The incidence of all cancers is projected to double by 2020, primarily due to ageing and also possibly due to increased exposure to risk factors for cancer. Breast cancer is the most common cancer among Paris females (and the most prevalent cancer in both sexes combined), lung cancer is the most common cancer amongst Paris males but is extremely rare in females, which reflects the prevalence of smoking (33.0% vs. 0.5%, respectively), and colorectal cancer is the second most common cancer.

    Approximately 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of the deaths occurred in the economically developing world.

Hospitals  in USA and Atlanta

• Winship Cancer Institute of Emory University
• Emory University Hospital
• Piedmont Atlanta Hospital
• WellStar Atlanta Medical Center
• Northside Hospital Atlanta
• Hughes Spalding Children's Hospital
• Anchor Hospital
• Johns Hopkins Hospital in Baltimore
• Massachusetts General Hospital in Boston
• Brigham and Women's Hospital in Boston
• University of Pittsburgh Medical Center in Pennsylvania
• UCSF Medical Center in San Francisco
• Cedars-Sinai Medical Center, Los Angeles, CA
• St Francis Hospital, Roslyn, New York, NY
• BaylorScott & White Hospital
• Emory University Hospital Midtown
• Lankenau Medical Center
• Kettering Medical Center
• JFK Medical Center
• Mount Auburn Hospital
• St. Mark's Hospital

List of Societies and Associations around the World

• American Cancer Society
• World Health Organization 
• American Association for Cancer Research
• American Society of Clinical Oncology
• European Oncology nursing Society
• Canadian Cancer Society
• European Cancer Organization
• European Association for Cancer Research
• European Society of Surgical Oncology
• National Children’s Cancer Society
• International Gynaecologic Cancer Society
• Testicular Cancer Society
• American Childhood Cancer Organization
• International Society of Pediatric Oncology
• The Cancer Control Society
• Society of gynaecologic Nurse Oncologists
• American Institute of Ultrasound in Medicine (AIUM)  
• American Medical Association (AMA)  
• American Nuclear Society (ANS)  
• American Osteopathic College of Radiology (AOCR) 
• American Radium Society (ARS)  

Medical Universities in world:

• University of Toronto, Canada
• Thomas Jefferson University
• University of Chicago, Chicago
• University of Wisconsin, Madison-
• Washington University in St. Louis
• University of Tokoyo, Japan
• National University of Singapore (NUS), Singapore 
• Guangxi Medical University, Nanning, China
• Indianapolis University “La Sapienza” of Rome, Rome, Italy 
• University of Lyon, France
• University Of Leeds 
• University Of Queensland,Australia
• University of Arizona Cancer Center
• University of Utah
• Georgetown University Medical Center
•  University of Southampton
• University of Pittsburgh
•  McMaster University
• University Of Florida
• Vanderbilt University School of Medicine
• Wayne State University School of Medicine
• University of Alberta
• University Of British Columbia 
• University Of Leicester 
•  University Of Chester
• University of Kentucky
• University of north Durham
•  University Of Surrey
•  University Of Edinburgh
•  University of Glasgow
•  University Of Bordeaux,France
• Oregon Health and Science University
• Knight Cancer Institute
• Loyola University Chicago
• University oF Louisville
• University of Toledo
• Rutgers University
• University Of Calgary
• University Of Witaterstrand
• University Of Western Sydney, Australia
• University of Melbourne
• University Of South Australia
• University Of New South Wales
• Monash University, Australia
• University of Milan, Italy
• Kyoto University, Japan
• The University of Auckland, NZ
• University Of Zurich
• National Taiwan University 
• The University of Manchester, UK
• Ichan School of medicine, Mount Sinai
• Pondicherry University, India
• University of phoenix
• Griffith University
• University Of Exeter
• Crimea State Medical University,Ukriane
• Heidelberg University
• Hackensack University Medical Center
• Kyoto University, Taiwan
• Osaka University, Japan
• Kursk State Medical University, Russia 

Market Report on Cancer Drugs

The market of Cancer Drugs and Therapeutics is conveyed to indicate steady improvement rate in the midst of the gage time span from 2012 – 2020. This improvement is driven by main issue, for instance, rising inescapability of various afflictions and expansive R&D hones are on-going over the globe to bring new and more fruitful medicines and definitions in the market. Oncology has been able to be one of the genuine focus areas for pharmaceutical and biotechnology associations in light of the high ignored necessity for improved solutions for various sorts of danger. The overall development grandstand in 2010 was regarded at $54bn, an extension of 5.1% over the prior year's offers of $51.3bn, and is resolved to create at a CAGR of 6.9% from 2010-16; accomplishing $81bn in 2016.GMR Data gage that the overall infection meds and pharmaceuticals market will reach $143.7bn by 2023.

Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer. Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. When cancer begins, it produces no symptoms. Signs and symptoms appear as the mass grows. The majority of cancers, some 90–95% of cases, are due to environmental factors. The remaining 5–10% is due to inherited genetics. Environmental, as used by cancer researchers, means any cause that is not inherited genetically, such as lifestyle, economic and behavioural factors and not merely pollution. Common environmental factors that contribute to cancer death include tobacco (25–30%), diet and obesity (30–35%), infections (15–20%), radiation (both ionizing and non-ionizing, up to 10%), stress, lack of physical activity and environmental pollutants. Many treatment options for cancer exist. The primary ones include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy and palliative care Chemotherapy is the treatment of cancer with one or more cytotoxic anti-neoplastic drugs. Radiation therapy involves the use of ionizing radiation in an attempt to either cure or improve symptoms. Surgery is the primary method of treatment for most isolated, solid cancers and may play a role in palliation and prolongation of survival. Palliative care refers to treatment that attempts to help the patient feel better and may be combined with an attempt to treat the cancer. A variety of therapies using immunotherapy, stimulating or helping the immune system to fight cancer. 

Market value for preventive oncology

The worldwide market for cancer treatments was worth $150.6 billion out of 2012 and this should increment to over $195.6 billion by 2020, a compound yearly development rate (CAGR) of 14.6%. Albeit huge enhancements in the determination and advancement of different mixes to treat growth have been made, malignancy remains a noteworthy medicinal services challenge around the world. In the 21st century, the repeat of development and the anguish regularly associated with it has through and through raised threat care. Radiation treatment, close by chemotherapy and surgery, is used to treat tumor. It is evaluated that radiation treatment is coordinated to half of all danger patients. The disclosure of X-bars and radioactivity provoke the change of radiation treatment techniques. The market for radiotherapy was evaluated at $5.8 billion of every 2014 and is anticipated to increase at a compound yearly advancement rate (CAGR) of 6.7% to $8 billion by 2019.External Beam Radiation Therapy (EBRT) charges the greatest bestow of the radiation treatment market to a normal 84% or $4.9 billion in salary.